Stocks and InvestingStocks and Investing
Wed, April 3, 2024
Tue, April 2, 2024
Mon, April 1, 2024

Etzer Darout Reiterated (ACRV) at Buy and Held Target at $18 on, Apr 1st, 2024


Published on 2024-10-28 10:01:27 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of BMO Capital, Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $18 on, Apr 1st, 2024.

Etzer has made no other calls on ACRV in the last 4 months.



There is 1 other peer that has a rating on ACRV. Out of the 1 peers that are also analyzing ACRV, 0 agree with Etzer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Etzer


  • Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024